The PilA protein involved in pili formation is the correct answer as a structural drug target for disrupting P. aeruginosa biofilm formation.
Rationale for Target Selection
Pili (specifically Type IV pili containing PilA protein) are essential for initial bacterial adhesion to surfaces, which is the critical first step in biofilm formation. Without successful adhesion, biofilm development cannot proceed, making this an ideal intervention point 1.
Why PilA/Pili Formation is the Best Target:
The structural evidence strongly supports targeting adhesion mechanisms:
Recent structural studies (2026) have identified specific adhesive domains like CdrA (a fibrillar adhesin) that mediate cell-cell interactions within biofilms in a polysaccharide-dependent manner 2. Structure-guided mutagenesis of adhesive domains abolishes bacterial aggregation and strongly attenuates biofilm formation 2.
Adhesion proteins represent validated drug targets with demonstrated efficacy - inhibitory nanobodies targeting adhesins like CdrA reduce biofilm formation by binding to critical adhesive epitopes 2.
The adhesive domains are highly conserved across the P. aeruginosa pangenome, making them excellent therapeutic targets that won't easily develop resistance 2.
Why the Other Options Are Less Suitable:
Flagellum (Option 1): While important for motility in planktonic bacteria, flagella are primarily relevant for initial surface approach but not the sustained adhesion and biofilm architecture that drives chronic infection pathogenicity 3.
Ribosomal RNA (Option 3): This is a general metabolic target, not specific to biofilm formation. Targeting this would be equivalent to conventional antibiotics, which biofilms resist through 100-1,000 times higher tolerance 4.
Peptidoglycan layer (Option 4): This provides general structural integrity but is not specific to biofilm formation mechanisms. Biofilms in their matrix-protected state show enhanced resistance to cell wall-targeting antibiotics 3.
Clinical Context
Biofilm infections cause chronic, persistent infections despite adequate antibiotic therapy because microorganisms in biofilm mode are physiologically much more resistant (100-1,000× higher antibiotic concentrations needed) 3, 4. Targeting the initial adhesion step through pili/adhesins prevents biofilm establishment rather than trying to penetrate established biofilms, which is the more effective strategy 2.